Your email has been successfully added to our mailing list.

×
0.0833333333333334 -0.235583333333333 -0.191666666666667 -0.15 -0.1825 -0.225833333333333 -0.301666666666667 -0.264833333333333
Stock impact report

DURECT and Gilead Enter into License Agreement for Long-Acting Injectable HIV Investigational Product

DURECT Corporation (DRRX) 
Last durect corporation earnings: 3/3 04:05 pm Check Earnings Report
US:NASDAQ Investor Relations: durect.com/investors
Company Research Source: PR Newswire
CUPERTINO, Calif., July 22, 2019 /PRNewswire/ -- DURECT Corporation (Nasdaq: DRRX) announced today that it has entered into an agreement with Gilead Sciences, Inc. granting Gilead the exclusive worldwide rights to develop and commercialize a long-acting injectable HIV product utilizing DURECT's SABER® technology.  Gilead also received exclusive access to the SABER® platform for HIV and Hepatitis B Virus (HBV) and the exclusive option to license additional SABER-based products directed to HIV and HBV."We're pleased to be working on this program with Gilead given their expertise and global leadership in the HIV and HBV fields," stated James E. Brown, President and CEO of DURECT. "We've been working together on this program as a feasibility project, and are now delighted that Gilead has chosen to advance this effort into a formal development program."Under the terms of the agreement, Gilead will make an upfront payment to DURECT of $25 million, with the potential for up to an additional Show less Read more
Impact Snapshot
Event Time:
DRRX
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison Updated
Event Day
Stock performance from the time of news release until the following 4pm ET market close
Last price at news event
Since Event
Multi-day stock performance from the time of the news release
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
LAST
PRICE AT
NEWS EVENT
SINCE EVENT
Multi-day stock performance from the time of the news release
Last Price
VWAP
High:
Max Up
High:
Low:
Max Down
Low:
%
Post news range
%
Price change

Price Change Percentage


S&P 500
(SPX)

%

Volume ratio
%

Volume
Ticks

Avg transaction size

Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Opt-in for DRRX alerts
Opt-in for
DRRX alerts

from News Quantified
Opt-in for
DRRX alerts

from News Quantified